Screener / SEC EDGAR /CIK 0000019584 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
NYSE Health care · Home Health Care Services

Chemed Corp CHE

Headquarters
Cincinnati, OH
CEO
Kevin J. McNamara
Next results
around Feb 24, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $2.5B through the costs to a net profit of $265.2M · income statement of the 10-K

13% operating margin
Revenue to Gross profit: $823.2MRevenue to Cost of revenue: $1.7BGross profit to Operating profit: $338.2MGross profit to Operating expenses: $484.9MOperating profit to Net profit: $265.2MOperating profit to Tax & other: $73.0M Revenue: $2.5B REVENUE $2.5B +4% Y/Y Gross profit: $823.2M · 33% margin GROSS PROFIT $823.2M 33% margin Cost of revenue: $1.7B · 67% of revenue COST OF REVENUE $1.7B 67% of revenue Operating profit: $338.2M · 13% margin OPERATING PROFIT $338.2M 13% margin · −8% Y/Y Operating expenses: $484.9M · 19% of revenue OPERATING EXPENSES $484.9M 19% of revenue Net profit: $265.2M · 10% margin NET PROFIT $265.2M 10% margin · −12% Y/Y Tax & other: $73.0M · 3% of revenue TAX & OTHER $73.0M 3% of revenue
Gross profit $823.2M 33% margin
Operating profit $338.2M 13% margin · −8% Y/Y
Net profit $265.2M 10% margin · −12% Y/Y
The full income statement, year by year

CHE among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.

Compare
Revenue growth: 4.1%, above 23% of 154 peers (their median 10.5%) REVENUE GROWTH 4.1% · above 23% Gross margin: 33.5%, above 18% of 107 peers (their median 63.8%) GROSS MARGIN 33.5% · above 18% Operating margin: 13.9%, above 66% of 138 peers (their median 9.8%) OPERATING MARGIN 13.9% · above 66% Net margin: 10.6%, above 63% of 153 peers (their median 6.7%) NET MARGIN 10.6% · above 63% FCF margin: 11.1%, above 54% of 144 peers (their median 9.9%) FCF MARGIN 11.1% · above 54% Return on capital: 23.0%, above 91% of 89 peers (their median 9.0%) RETURN ON CAPITAL 23.0% · above 91%
CHE Peer median Below the median

What changed

11 new risk paragraphs. 10-K filed Feb 27, 2026 against Feb 28, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +6.7% ($171.2M to $182.6M) vs revenue +4.1% ($2.4B to $2.5B), +2.6 pts apart
  • Cash from operations $388.3M vs net income $265.2M (FY ending Dec 31, 2025)
  • Inventory -7.9% ($8.2M to $7.5M) vs revenue +4.1% ($2.4B to $2.5B), -12.0 pts apart
8 more checks with nothing to note
  • Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: VITAS Revenue Implicit Price Concessions
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

11 paragraphs in Risk Factors that were not in the 10-K filed Feb 28, 2025. Quoted as filed.

All 11 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    Despite significant safeguards, including active intrusion protection, firewalls and virus detection software, as discussed in greater detail on Item 1C below, in October of 2025, access to our systems was gained by a threat actor in a cybersecurity attack. The threat actor was able to access a significant amount of Protected Health…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    While we have been able to mitigate the damages from the prior successful attack, and did not experience any material operational or financial issues as a result of the attack, a subsequent successful attack on our information technology systems could have even greater consequences to the business including liability for compromised…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    Significant Tariffs Could Increase Costs, Decrease Margin, and Materially Adversely Affect the Business. Both Roto-Rooter’s and VITAS’s primary businesses are the provision of services within the United States. Accordingly, they are likely to be less affected by the impact of specific or wide-ranging tariffs than many other entities in…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$2.1B$2.3B$2.4B$2.5B
Net income$249.6M$272.5M$302.0M$265.2M
Operating cash flow$309.9M$330.3M$417.5M$388.3M
Free cash flow$252.6M$273.4M$368.0M$325.5M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$2.5B ▲ 4.1% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

3 filings in the last 30 days · SEC EDGAR

All filings

About the company

Chemed Corp, Cincinnati, OH · from the 10-K filed Feb 27, 2026

Chemed Corporation (the “Company” or “Chemed”) was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co. and succeeded to the business of W.R. Grace & Co.’s Special Products Group as of April 30, 1971 and remained a subsidiary of W.R. Grace & Co. until March 10, 1982. Chemed purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value. The Company’s day to day operating businesses are managed on a decentralized basis. There are few integrated business functions between the operating units and Chemed (such as sales, marketing or purchasing).

Headquarters
Cincinnati, OH
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 27, 2026
Incorporated in
DE

Email alerts

Sources

The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Feb 28, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHE/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.